Dynamics of a virological model for cancer therapy with innate immune response (Q2210257): Difference between revisions
From MaRDI portal
Set OpenAlex properties. |
ReferenceBot (talk | contribs) Changed an Item |
||
Property / cites work | |||
Property / cites work: Analysis of virotherapy in solid tumor invasion / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: The role of the innate immune system in oncolytic virotherapy / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Hopf bifurcation analysis and optimal control of treatment in a delayed oncolytic virus dynamics / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Introduction to functional differential equations / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Q3989350 / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Q4141027 / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Geometric Stability Switch Criteria in Delay Differential Systems with Delay Dependent Parameters / rank | |||
Normal rank |
Latest revision as of 23:30, 23 July 2024
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Dynamics of a virological model for cancer therapy with innate immune response |
scientific article |
Statements
Dynamics of a virological model for cancer therapy with innate immune response (English)
0 references
5 November 2020
0 references
Summary: The aim of this work is to present a virological model for cancer therapy that includes the innate immune response and saturation effect. The presented model combines both the evolution of a logistic growing tumor and time delay which stands for the period of the viral lytic cycle. We use the delay differential equation in order to model this time which also means the time needed for the infected tumor cells to produce new virions after viral entry. We show that the delayed model has four equilibria which are the desired outcome therapy equilibrium, the complete failure therapy equilibrium, the partial success therapy free-immune equilibrium when the innate immune response has not been established, and the partial success therapy equilibrium with immune response. Furthermore, the stability analysis of equilibria and the Hopf bifurcation are properly exhibited.
0 references
0 references